QUANTIFY CANCER
Help de-risk and accelerate your drug approval with
ctDNA-based MRD and response
monitoring.1-3
Guardant Infinity can help bring effective new cancer therapeutics to patients—faster.
Enrich clinical trial populations to decrease
trial size and accelerate patient enrollment¹
Gain early insights into therapy response²
Develop a surrogate endpoint or determine dosing with ctDNA reduction or clearance³
ctDNA, circulating tumor DNA; MRD, molecular residual disease.
Guardant Infinity is for Research Use Only. Not for use in diagnostic procedures
InfinityAI is not a standalone customer product. “Powered by InfinityAI” refers to Guardant Health artificial intelligence and machine learning technology used in development of product features. These features are reported as professional service and have not been cleared or approved by the US FDA.
Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma InfinityAI for BioPharma